YOLFTbeta
00

Samjin Pharm

005500 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

19,760.00KRW-50.00 (-0.25%)

Price History

Full chart

Market Stats

Previous Close19,810.00
Open19,620.00
Day Range19,560.00 – 20,500.00
52-Week Range16,580.00 – 25,900.00
Volume109.96K
Market Cap245.31B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield4.27%
Beta0.24
50-Day Avg18,271.60
200-Day Avg18,910.95

About

Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine. It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, such as Gevorin, an anti-infalammatory pain killer; Trestan, an appetite stimulant; Flaris, an anti-thrombotic agent; and Nutilin, a brain function improvement agent, as well as medicine for treatment of chronic diseases. It also develops SA001, which is in Phase II clinical trial for the treatment for dry eye syndrome and Sjogren syndrome; SJP1804 medicine that is Phase I clinical trial to treat macular degeneration; and SJP1604, which is in Phase I clinical trial for cancer; SJP1901 and SJP1902 for cancer treatment; SJP 1801 to treat Alzheimer's and Parkinson's disease; SJP006, an anti-viral product; and SJP003 for treatment of diabetes. In addition, the company's preclinical product is SJP1602 for the treatment of cancer. Samjin Pharmaceuticals Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Kyu Seok Cho
  • Employees586
  • Headquarters121 Wausan Ro, Seoul, South Korea, 04054, Korea
  • Websitehttps://www.samjinpharm.co.kr

Leadership

  • Mr. Kyu Seok ChoPresident, CEO & Chairman · b. 1971
  • Ms. Ji-hyeon ChoiPresident, CEO & Director · b. 1974
  • Mr. Kyu Hyung ChoVP, Internal Director & Head of Sales · b. 1975
  • Ms. Jee Sun ChoiVP & Internal Director · b. 1977
  • Mr. Kim Jung-ilProduction Head · b. 1961

Financials

Income Statement

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue192.01B201.31B216.51B239.31B245.27B260.02B241.93B235.16B250.07B274.03B292.13B308.35B309.13B
Growth (%)-+4.84%+7.55%+10.53%+2.49%+6.01%-6.96%-2.79%+6.34%+9.58%+6.60%+5.55%+0.25%
Cost of Revenue75.04B89.31B96.67B109.97B109.29B117.24B121.21B124.65B132.24B156.30B175.45B179.38B184.05B
Gross Profit116.97B111.99B119.84B129.35B135.98B142.78B120.71B110.52B117.83B117.73B116.68B128.97B125.08B
Gross Margin60.92%55.63%55.35%54.05%55.44%54.91%49.90%47.00%47.12%42.96%39.94%41.82%40.46%
Operating Expense86.87B80.41B83.87B87.29B89.04B83.24B75.82B78.27B83.92B94.55B96.20B97.33B98.30B
Operating Income30.09B31.58B35.97B42.06B46.95B59.54B44.90B32.24B33.91B23.18B20.48B31.64B26.78B
Operating Margin15.67%15.69%16.61%17.57%19.14%22.90%18.56%13.71%13.56%8.46%7.01%10.26%8.66%
EBITDA----53.25B66.34B28.37B39.36B42.41B36.81B36.60B65.92B46.87B
EBITDA Margin----21.71%25.51%11.73%16.74%16.96%13.43%12.53%21.38%15.16%
Net Income7.88B20.72B27.04B30.17B35.80B25.53B11.88B27.88B28.40B21.89B18.91B39.23B24.17B
Net Income Margin4.10%10.29%12.49%12.61%14.59%9.82%4.91%11.86%11.36%7.99%6.47%12.72%7.82%
R&D7.62B3.29B2.77B2.80B3.65B3.74B2.60B1.51B2.58B3.66B4.17B4.50B4.39B
R&D as % of Total Revenue3.97%1.64%1.28%1.17%1.49%1.44%1.08%0.64%1.03%1.33%1.43%1.46%1.42%
Interest Expense0000034.88M24.15M41.75M141.92M1.76B4.43B4.88B4.95B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.02%0.06%0.64%1.51%1.58%1.60%

Balance Sheet

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets203.95B209.31B220.74B227.57B241.85B250.27B244.15B269.03B332.50B406.56B419.90B425.17B470.53B
Total Liabilities90.96B83.26B72.67B57.88B48.38B44.95B46.68B55.58B98.33B130.69B154.54B163.51B180.14B
Total Equity112.98B126.04B148.06B169.69B193.47B205.32B197.47B213.46B234.17B275.34B265.36B261.66B290.39B
Cash2.58B2.69B886.77M11.91B21.91B30.70B31.90B18.91B7.94B2.34B2.40B3.42B12.08B
Net Debt--------46.06B84.49B115.60B116.75B122.42B

Cash Flow

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.37B32.41B18.94B48.66B37.28B30.08B23.63B23.86B23.97B17.29B8.33B38.15B24.11B
Investing Cash Flow-5.11B-12.87B-10.14B-10.63B-8.59B--------
Financing Cash Flow-2.18B-19.42B-10.60B-27.00B-18.69B--------
Capital Expenditure6.83B13.35B7.66B7.80B8.86B8.24B12.04B30.60B74.60B35.50B20.72B18.34B14.49B
Free Cash Flow----28.11B21.85B11.59B-6.74B-50.64B-18.20B-12.39B19.81B9.62B
Dividends Paid3.81B4.98B6.23B7.47B8.72B9.84B9.84B9.84B9.84B9.84B10.58B10.22B9.81B
FCF to OCF----75.40%72.62%49.06%-28.23%-211.27%-105.27%-148.65%51.94%39.89%
Dividend Paid to FCF----31.01%45.05%84.88%-146.10%-19.44%-54.06%-85.45%51.58%101.96%

Earnings

Report DateApr 3, 2009Jul 2, 2009Oct 5, 2009Mar 3, 2010Apr 2, 2010Jul 1, 2010Oct 4, 2010Mar 2, 2011Apr 8, 2011Jul 7, 2011Oct 3, 2011Feb 29, 2012May 15, 2012Aug 14, 2012Oct 1, 2012Feb 27, 2013Apr 5, 2013Jul 4, 2013Nov 14, 2013Feb 26, 2014Apr 4, 2014Jul 3, 2014Nov 3, 2014Feb 9, 2015Apr 27, 2015Jul 29, 2015Oct 27, 2015Feb 1, 2016Apr 26, 2016Jul 25, 2016Oct 25, 2016Jan 31, 2017Apr 25, 2017Jul 24, 2017Oct 25, 2017Jan 31, 2018Apr 24, 2018Jul 29, 2018Nov 14, 2018Mar 14, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 3, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Feb 1, 2021May 14, 2021Aug 17, 2021Nov 15, 2021Mar 17, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Feb 6, 2023May 15, 2023Aug 11, 2023Nov 13, 2023Mar 14, 2024May 16, 2024Aug 14, 2024Nov 14, 2024Feb 3, 2025May 15, 2025Jun 30, 2025Nov 12, 2025Feb 2, 2026May 13, 2026Jun 30, 2026
EPS Estimate------------218.15304.20----155.03--------461.00494.00-----683.00469.50747.00---------------------------------
EPS Actual245.75153.24128.5020.98255.41152.74263.49124.80316.8411.56269.32-55.84155.00183.00267.94211.28479.79-700.20442.00403.00518.95475.16466.56202.94529.39575.37585.54482.00647.00668.44732.18375.71690.10780.61853.00568.00877.00955.75932.52-690.00931.97-906.00747.43143.66690.00653.00443.00480.01553.00668.001286.00-196.68-196.68340.34337.34740.55662.4662.40245.57577.37242.581947.17358.54556.36303.66381.72557.74719.55110.11481.80
Surprise-------------28.95%-39.84%----185.11%--------4.56%30.97%-----24.89%20.98%17.40%---------------------------------
Timing------------Pre-marketAfter-hours----Pre-market---Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap245.31B
Enterprise Value342.54B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.90
Price / Book0.78
Revenue (TTM)274.03B
Gross Profit (TTM)117.73B
EBITDA33.00B
Profit Margin7.99%
Operating Margin22.57%
Return on Equity8.59%
Return on Assets3.92%
Shares Outstanding12.66M
Shares Float7.94M
Beta0.24
Dividend Yield4.27%
Dividend Rate800.00
Payout Ratio42.80%

Dividends

20251×
800.00Dec 29, 2025
20241×
800.00Dec 27, 2024
20231×
800.00Dec 27, 2023
20221×
800.00Dec 28, 2022
20211×
800.00Dec 29, 2021
20201×
800.00Dec 29, 2020
20191×
800.00Dec 27, 2019
20181×
800.00Dec 27, 2018
20171×
800.00Dec 27, 2017
20161×
700.00Dec 28, 2016
20151×
600.00Dec 29, 2015
20141×
500.00Dec 29, 2014
20131×
400.00Dec 27, 2013
20121×
300.00Dec 27, 2012
20111×
220.00Dec 28, 2011
20101×
50.00Dec 29, 2010
20091×
29.09Dec 29, 2009
20081×
28.23Dec 29, 2008
20071×
91.30Dec 27, 2007
20061×
160.94Dec 27, 2006
20051×
148.24Dec 28, 2005
20041×
130.80Dec 29, 2004
20031×
130.80Dec 29, 2003
20021×
104.64Dec 27, 2002

Stock Splits

  • Dec 29, 20101.0312:1
  • Dec 29, 20091.0305:1
  • Dec 29, 20081.0307:1
  • Apr 18, 20085:1
  • Dec 27, 20071.0211:1